HEADER HYDROLASE, LIGASE 27-OCT-05 2ETL TITLE CRYSTAL STRUCTURE OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCH-L1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN CARBOXYL-TERMINAL HYDROLASE ISOZYME L1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: UCH-L1, UBIQUITIN THIOLESTERASE L1, NEURON CYTOPLASMIC COMPND 5 PROTEIN 9.5, PGP 9.5, PGP9.5; COMPND 6 EC: 3.4.19.12, 6.-.-.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: UCHL1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-6P1 KEYWDS DEUBIQUITINATING THIOL HYDROLASE, HYDROLASE, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR C.DAS,Q.Q.HOANG,C.A.KREINBRING,S.J.LUCHANSKY,R.K.MERAY,S.S.RAY, AUTHOR 2 P.T.LANSBURY,D.RINGE,G.A.PETSKO REVDAT 6 03-APR-24 2ETL 1 REMARK REVDAT 5 14-FEB-24 2ETL 1 REMARK SEQADV REVDAT 4 18-OCT-17 2ETL 1 REMARK REVDAT 3 13-JUL-11 2ETL 1 VERSN REVDAT 2 24-FEB-09 2ETL 1 VERSN REVDAT 1 28-MAR-06 2ETL 0 JRNL AUTH C.DAS,Q.Q.HOANG,C.A.KREINBRING,S.J.LUCHANSKY,R.K.MERAY, JRNL AUTH 2 S.S.RAY,P.T.LANSBURY,D.RINGE,G.A.PETSKO JRNL TITL STRUCTURAL BASIS FOR CONFORMATIONAL PLASTICITY OF THE JRNL TITL 2 PARKINSON'S DISEASE-ASSOCIATED UBIQUITIN HYDROLASE UCH-L1. JRNL REF PROC.NATL.ACAD.SCI.USA V. 103 4675 2006 JRNL REFN ISSN 0027-8424 JRNL PMID 16537382 JRNL DOI 10.1073/PNAS.0510403103 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 34753 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.200 REMARK 3 FREE R VALUE TEST SET COUNT : 3369 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3482 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 4 REMARK 3 SOLVENT ATOMS : 107 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.03800 REMARK 3 B22 (A**2) : -4.03800 REMARK 3 B33 (A**2) : 8.07600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 47.87 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : CNS_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : CNS_TOPPAR:PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CNS_TOPPAR:DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : CNS_TOPPAR:WATER.TOP REMARK 3 TOPOLOGY FILE 4 : CNS_TOPPAR:ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ETL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1000035075. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-05 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98397 REMARK 200 MONOCHROMATOR : SI(311) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34753 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 41.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 14.10 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 14.30 REMARK 200 R MERGE FOR SHELL (I) : 0.77300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: HOMOLOGY MODEL BASED ON UCH-L3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.4 M AMMONIUM SULFATE, 0.1 M HEPES, REMARK 280 PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.04850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.04850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.04850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.04850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.04850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.04850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.04850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.04850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER, A SUBUNIT OF THE REMARK 300 ASSYMETRIC UNIT WHICH CONTAINS TWO COPIES OF THE PROTEIN MOLECULE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 11020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -106.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 220.19400 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 110.09700 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 165.14550 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 -55.04850 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 55.04850 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 165.14550 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 110.09700 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 55.04850 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 -55.04850 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 55.04850 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 55.04850 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 GLY B -4 REMARK 465 PRO B -3 REMARK 465 LEU B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 43 105.30 -59.91 REMARK 500 ASN A 102 31.50 -146.28 REMARK 500 ARG A 153 -96.64 -166.02 REMARK 500 VAL A 154 132.80 61.37 REMARK 500 ASN A 159 59.25 -68.83 REMARK 500 GLN A 209 -6.93 -54.01 REMARK 500 GLN B 2 145.03 -173.31 REMARK 500 ALA B 23 -126.49 13.74 REMARK 500 GLU B 35 -129.30 -77.66 REMARK 500 PHE B 62 -52.72 77.19 REMARK 500 ASN B 102 34.17 -144.08 REMARK 500 PHE B 108 124.26 68.22 REMARK 500 GLU B 109 -179.94 -59.76 REMARK 500 ASP B 110 -85.39 -52.53 REMARK 500 LYS B 123 45.51 36.79 REMARK 500 ASP B 155 166.31 -14.43 REMARK 500 ASP B 156 -103.98 -69.51 REMARK 500 HIS B 185 42.30 -97.36 REMARK 500 THR B 192 24.28 -73.63 REMARK 500 ARG B 207 24.31 -62.75 REMARK 500 ALA B 222 85.86 58.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 3001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 3002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 3003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 3004 DBREF 2ETL A 1 223 UNP P09936 UCHL1_HUMAN 1 223 DBREF 2ETL B 1 223 UNP P09936 UCHL1_HUMAN 1 223 SEQADV 2ETL GLY A -4 UNP P09936 CLONING ARTIFACT SEQADV 2ETL PRO A -3 UNP P09936 CLONING ARTIFACT SEQADV 2ETL LEU A -2 UNP P09936 CLONING ARTIFACT SEQADV 2ETL GLY A -1 UNP P09936 CLONING ARTIFACT SEQADV 2ETL SER A 0 UNP P09936 CLONING ARTIFACT SEQADV 2ETL GLY B -4 UNP P09936 CLONING ARTIFACT SEQADV 2ETL PRO B -3 UNP P09936 CLONING ARTIFACT SEQADV 2ETL LEU B -2 UNP P09936 CLONING ARTIFACT SEQADV 2ETL GLY B -1 UNP P09936 CLONING ARTIFACT SEQADV 2ETL SER B 0 UNP P09936 CLONING ARTIFACT SEQRES 1 A 228 GLY PRO LEU GLY SER MET GLN LEU LYS PRO MET GLU ILE SEQRES 2 A 228 ASN PRO GLU MET LEU ASN LYS VAL LEU SER ARG LEU GLY SEQRES 3 A 228 VAL ALA GLY GLN TRP ARG PHE VAL ASP VAL LEU GLY LEU SEQRES 4 A 228 GLU GLU GLU SER LEU GLY SER VAL PRO ALA PRO ALA CYS SEQRES 5 A 228 ALA LEU LEU LEU LEU PHE PRO LEU THR ALA GLN HIS GLU SEQRES 6 A 228 ASN PHE ARG LYS LYS GLN ILE GLU GLU LEU LYS GLY GLN SEQRES 7 A 228 GLU VAL SER PRO LYS VAL TYR PHE MET LYS GLN THR ILE SEQRES 8 A 228 GLY ASN SER CYS GLY THR ILE GLY LEU ILE HIS ALA VAL SEQRES 9 A 228 ALA ASN ASN GLN ASP LYS LEU GLY PHE GLU ASP GLY SER SEQRES 10 A 228 VAL LEU LYS GLN PHE LEU SER GLU THR GLU LYS MET SER SEQRES 11 A 228 PRO GLU ASP ARG ALA LYS CYS PHE GLU LYS ASN GLU ALA SEQRES 12 A 228 ILE GLN ALA ALA HIS ASP ALA VAL ALA GLN GLU GLY GLN SEQRES 13 A 228 CYS ARG VAL ASP ASP LYS VAL ASN PHE HIS PHE ILE LEU SEQRES 14 A 228 PHE ASN ASN VAL ASP GLY HIS LEU TYR GLU LEU ASP GLY SEQRES 15 A 228 ARG MET PRO PHE PRO VAL ASN HIS GLY ALA SER SER GLU SEQRES 16 A 228 ASP THR LEU LEU LYS ASP ALA ALA LYS VAL CYS ARG GLU SEQRES 17 A 228 PHE THR GLU ARG GLU GLN GLY GLU VAL ARG PHE SER ALA SEQRES 18 A 228 VAL ALA LEU CYS LYS ALA ALA SEQRES 1 B 228 GLY PRO LEU GLY SER MET GLN LEU LYS PRO MET GLU ILE SEQRES 2 B 228 ASN PRO GLU MET LEU ASN LYS VAL LEU SER ARG LEU GLY SEQRES 3 B 228 VAL ALA GLY GLN TRP ARG PHE VAL ASP VAL LEU GLY LEU SEQRES 4 B 228 GLU GLU GLU SER LEU GLY SER VAL PRO ALA PRO ALA CYS SEQRES 5 B 228 ALA LEU LEU LEU LEU PHE PRO LEU THR ALA GLN HIS GLU SEQRES 6 B 228 ASN PHE ARG LYS LYS GLN ILE GLU GLU LEU LYS GLY GLN SEQRES 7 B 228 GLU VAL SER PRO LYS VAL TYR PHE MET LYS GLN THR ILE SEQRES 8 B 228 GLY ASN SER CYS GLY THR ILE GLY LEU ILE HIS ALA VAL SEQRES 9 B 228 ALA ASN ASN GLN ASP LYS LEU GLY PHE GLU ASP GLY SER SEQRES 10 B 228 VAL LEU LYS GLN PHE LEU SER GLU THR GLU LYS MET SER SEQRES 11 B 228 PRO GLU ASP ARG ALA LYS CYS PHE GLU LYS ASN GLU ALA SEQRES 12 B 228 ILE GLN ALA ALA HIS ASP ALA VAL ALA GLN GLU GLY GLN SEQRES 13 B 228 CYS ARG VAL ASP ASP LYS VAL ASN PHE HIS PHE ILE LEU SEQRES 14 B 228 PHE ASN ASN VAL ASP GLY HIS LEU TYR GLU LEU ASP GLY SEQRES 15 B 228 ARG MET PRO PHE PRO VAL ASN HIS GLY ALA SER SER GLU SEQRES 16 B 228 ASP THR LEU LEU LYS ASP ALA ALA LYS VAL CYS ARG GLU SEQRES 17 B 228 PHE THR GLU ARG GLU GLN GLY GLU VAL ARG PHE SER ALA SEQRES 18 B 228 VAL ALA LEU CYS LYS ALA ALA HET CL A3003 1 HET CL A3004 1 HET CL B3001 1 HET CL B3002 1 HETNAM CL CHLORIDE ION FORMUL 3 CL 4(CL 1-) FORMUL 7 HOH *107(H2 O) HELIX 1 1 ASN A 9 LEU A 20 1 12 HELIX 2 2 THR A 56 LYS A 71 1 16 HELIX 3 3 SER A 89 ASN A 101 1 13 HELIX 4 4 SER A 112 THR A 121 1 10 HELIX 5 5 SER A 125 ASN A 136 1 12 HELIX 6 6 ASN A 136 GLN A 148 1 13 HELIX 7 7 THR A 192 ARG A 207 1 16 HELIX 8 8 ASN B 9 LEU B 20 1 12 HELIX 9 9 THR B 56 GLU B 69 1 14 HELIX 10 10 SER B 89 ASN B 101 1 13 HELIX 11 11 SER B 112 GLU B 122 1 11 HELIX 12 12 SER B 125 GLU B 134 1 10 HELIX 13 13 ASN B 136 GLN B 148 1 13 HELIX 14 14 THR B 192 ARG B 207 1 16 SHEET 1 A 6 TRP A 26 ASP A 30 0 SHEET 2 A 6 SER A 215 LYS A 221 -1 O ALA A 218 N VAL A 29 SHEET 3 A 6 ALA A 46 PRO A 54 -1 N LEU A 52 O SER A 215 SHEET 4 A 6 PHE A 160 VAL A 168 -1 O ILE A 163 N LEU A 51 SHEET 5 A 6 HIS A 171 LEU A 175 -1 O TYR A 173 N ASN A 166 SHEET 6 A 6 VAL A 183 ALA A 187 -1 O GLY A 186 N LEU A 172 SHEET 1 B 6 ARG B 27 VAL B 31 0 SHEET 2 B 6 SER B 215 CYS B 220 -1 O ALA B 218 N VAL B 29 SHEET 3 B 6 ALA B 46 PRO B 54 -1 N LEU B 52 O SER B 215 SHEET 4 B 6 PHE B 160 ASN B 167 -1 O ILE B 163 N LEU B 51 SHEET 5 B 6 HIS B 171 LEU B 175 -1 O TYR B 173 N ASN B 166 SHEET 6 B 6 VAL B 183 ALA B 187 -1 O HIS B 185 N LEU B 172 CISPEP 1 ALA A 44 PRO A 45 0 -0.10 SITE 1 AC1 2 GLN B 84 ASN B 88 SITE 1 AC2 1 ASP B 169 SITE 1 AC3 2 GLN A 84 ASN A 88 SITE 1 AC4 1 ASP A 169 CRYST1 110.097 110.097 79.489 90.00 90.00 90.00 P 4 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009083 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009083 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012580 0.00000